Unicycive Therapeutics to Present Kidney Pipeline at Investment Conference

New York, Wednesday, 2 September 2026.
Unicycive Therapeutics will present its kidney disease drug pipeline, including an FDA-designated orphan drug, at the H.C. Wainwright conference on September 15, 2026.